Nocturnal Enuresis
40
3
3
22
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
7.5%
3 terminated out of 40 trials
88.0%
+1.5% vs benchmark
20%
8 trials in Phase 3/4
41%
9 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (40)
TENS Treatment for Bedwetting
Causes and Types of Nocturnal Enuresis in Children
Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency
Randomized Study Of Novel Enuresis Alarm vs Standard Bedwetting Alarm
Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children
PureWick™ France and U.S. At-Home Pilot Study
Aromatherapy Versus Diet
Effect of Use of DryNites Absorbent Pants on the Rate of Spontaneous Resolution of Paediatric Nocturnal Enuresis (NE)
Overnight Pant Study for Children With Nocturnal Enuresis
The Role of Timed Awakening in Treatment of Enuresis
Desmopressin for Bedwetting in Children With SCD
Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis
Effectiveness of Multimodal Pelvic Floor Rehabilitation Program in Children With Different Types of Urinary Incontinence
Vitamin D Serum Levels in Monosymptomatic Enuretic and Non Enuretic Children
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis
Biomarkers in Urine for Children With Monosymptomatic Nocturnal Enuresis and Nocturnal Polyuria
Treatment of Monosymptomatic Nocturnal Enuresis
Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production
Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease